Detalles de la búsqueda
1.
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria.
Lancet Rheumatol;
2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824935
2.
Patient-Reported Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Are the Answers in Front of Our Noses?
Arthritis Care Res (Hoboken);
2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706139
3.
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States.
Rheumatology (Oxford);
2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637947
4.
Current and future advances in practice: IgG4-related disease.
Rheumatol Adv Pract;
8(2): rkae020, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601138
5.
Case 11-2024: An 82-Year-Old Woman with Falls and Cognitive Decline.
N Engl J Med;
390(14): 1312-1322, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598798
6.
Multimodality Imaging Features of Immunoglobulin G4-related Vessel Involvement.
Radiol Cardiothorac Imaging;
6(2): e230105, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483247
7.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol;
51(5): 529-537, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428964
8.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol;
6(1): e21-e30, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258675
9.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis;
83(5): 680-682, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199795
10.
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.
Sci Transl Med;
16(731): eadk1599, 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38266109
11.
Predicting the spatial distribution of wintering golden eagles to inform full annual cycle conservation in western North America.
PLoS One;
19(1): e0297345, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295117
12.
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry.
Arthritis Care Res (Hoboken);
76(2): 274-287, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37643903
13.
Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide.
Arthritis Care Res (Hoboken);
76(2): 288-294, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37643919
14.
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.
J Rheumatol;
51(3): 305-312, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839812
15.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford);
2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070152
16.
Rheumatoid arthritis, quantitative parenchymal lung features, and mortality among smokers.
Rheumatology (Oxford);
2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048611
17.
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.
Ann Intern Med;
176(12): 1577-1585, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37956428
18.
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
Sci Transl Med;
15(724): eadh4529, 2023 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019932
19.
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
Semin Arthritis Rheum;
63: 152286, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37913612
20.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
medRxiv;
2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873462